Advertisement
Canada markets close in 1 hour 21 minutes
  • S&P/TSX

    21,748.49
    -39.99 (-0.18%)
     
  • S&P 500

    5,466.18
    -3.12 (-0.06%)
     
  • DOW

    39,143.16
    +31.00 (+0.08%)
     
  • CAD/USD

    0.7298
    -0.0025 (-0.34%)
     
  • CRUDE OIL

    80.87
    +0.04 (+0.05%)
     
  • Bitcoin CAD

    83,607.21
    -1,235.51 (-1.46%)
     
  • CMC Crypto 200

    1,265.68
    -18.10 (-1.41%)
     
  • GOLD FUTURES

    2,311.90
    -18.90 (-0.81%)
     
  • RUSSELL 2000

    2,013.30
    -9.05 (-0.45%)
     
  • 10-Yr Bond

    4.3180
    +0.0800 (+1.89%)
     
  • NASDAQ

    17,754.02
    +36.37 (+0.21%)
     
  • VOLATILITY

    12.60
    -0.24 (-1.87%)
     
  • FTSE

    8,225.33
    -22.46 (-0.27%)
     
  • NIKKEI 225

    39,667.07
    +493.92 (+1.26%)
     
  • CAD/EUR

    0.6830
    -0.0002 (-0.03%)
     

Gilead Stock Gains. It’s Trying to Get Into the Obesity Drug Game.

Gilead Stock Gains. It’s Trying to Get Into the Obesity Drug Game.

Gilead Sciences stock was climbing Friday on hopes that it would get into the obesity-drug game. GLP-1s, the technical name for the popular obesity drugs, has been one of the biggest drivers of pharmaceutical stocks in recent months. Which may be why Gilead stock has gained 2.8% to $64.55 in afternoon trading Friday after Jefferies released a note late Thursday night.